Cibus (NASDAQ:CBUS) Rating Lowered to Sell at Wall Street Zen

Cibus (NASDAQ:CBUS) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings downgraded Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, June 29th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $9.00.

Cibus Price Performance

Shares of CBUS stock opened at $1.61 on Friday. The firm has a 50-day moving average of $1.76 and a 200-day moving average of $1.80. Cibus has a one year low of $1.09 and a one year high of $4.19. The company has a market cap of $123.05 million, a P/E ratio of -0.98 and a beta of 1.59.

Cibus (NASDAQ:CBUS) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.10). Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%.The firm had revenue of $0.99 million for the quarter, compared to analysts’ expectations of $1.70 million. As a group, research analysts expect that Cibus will post -1.13 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Rockland Trust Co. purchased a new stake in shares of Cibus during the second quarter worth $41,000. Bank of America Corp DE grew its position in shares of Cibus by 324.2% in the first quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock valued at $147,000 after purchasing an additional 56,830 shares in the last quarter. Weiss Asset Management LP bought a new stake in shares of Cibus during the 1st quarter valued at $1,758,000. OMERS ADMINISTRATION Corp bought a new stake in shares of Cibus during the 1st quarter valued at $66,000. Finally, Renaissance Technologies LLC lifted its holdings in Cibus by 42.5% during the 1st quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock worth $196,000 after purchasing an additional 29,500 shares in the last quarter. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

About Cibus

Cibus, Inc is an agricultural biotechnology company that develops gene-edited traits for crops. Its technology is designed to make targeted changes to plant genetics without introducing foreign DNA, with the goal of improving crop performance, productivity and sustainability.

The company’s proprietary Rapid Trait Development System (RTDS) platform is used to develop traits for the global seed industry. Cibus has focused on crops including canola, soybean and rice, pursuing applications such as improved disease resistance, herbicide tolerance, reduced pod shatter and other traits intended to support farmers and seed companies.

Founded in 2001, Cibus became a publicly traded company following its 2023 merger with Calyxt, Inc The company is headquartered in San Diego, California, and works with agricultural and seed-industry partners to advance and commercialize gene-edited crop traits.